Background {#s1}
==========

Traumatic injuries are the leading cause of mortality in children and young adults, accounting for more than 45% of all deaths in patients 1--19 years of age in the USA.[@R1] Furthermore, ongoing disability following non-fatal traumatic injury affects approximately 50% of pediatric patients.[@R5] Due to hospital and long-term care expenses, the economic costs of pediatric trauma have been estimated at \$14 billion in lifetime medical spending and \$66 billion in present and future work loss.[@R8] Despite its impact on outcomes, there is much to learn about the pathophysiological processes and clinical constellations that drive mortality and morbidity following pediatric injury.

In adults, trauma-induced coagulopathy (TIC) seems to play a critical role in outcomes following trauma. Historically, all TIC was thought to be related to patient management. Now termed iatrogenic coagulopathy, this type of coagulopathy has been attributed to (1) dilution of coagulation factors after crystalloid and red blood cell resuscitation, (2) blood loss and consumption due to ongoing bleeding and procedures, (3) hypothermia from exposure and infusion of unwarmed resuscitation fluids, and (4) resultant acidosis.[@R11] Sixteen years ago, a distinct group of adult patients with trauma was described that present with coagulopathy prior to these exposures and interventions.[@R12] This early coagulopathy, referred to as either early TIC or acute traumatic coagulopathy (ATC), is an endogenous biologic response that occurs nearly immediately after injury and is independent of iatrogenic causes of dysfunctional hemostasis.[@R13] ATC is thought to be part of a pathway in which traumatic injury triggers a combination of mechanical tissue trauma, oxygen debt, and inflammation, which impairs coagulation and endothelial function.[@R14] With an incidence of 25% in adults, ATC has been associated with increased transfusion requirements, a greater incidence of organ dysfunction, a longer intensive care unit and overall hospital stay, and a fourfold increase in mortality in the adult population.[@R11]

There are a handful of retrospective studies describing ATC in the pediatric population.[@R17] While all have identified the presence of pediatric ATC, the incidence varies widely between studies (8.4%--57%).[@R17] In addition, all of these prior studies have found an association between pediatric ATC and mortality (OR 2.2 to 4.2). However, none have quantified the impact of ATC on multiple organ dysfunction syndrome (MODS). In pediatric populations, MODS is associated with an increased risk of mortality as well as short-term morbidity and serves as a validated proxy for poor outcomes when mortality rates may be too low to quantify the full effect of a clinical condition.[@R22] Because MODS has not been evaluated in pediatric ATC, the true impact of pediatric ATC may be significantly under-represented by prior studies focused on mortality. Given the significance of trauma in the pediatric population and this important limitation in prior pediatric ATC studies, the objective of this work is to describe the incidence and outcomes in pediatric ATC with specific focus on the relationship between pediatric ATC and MODS.

Methods {#s2}
=======

Study population {#s2-1}
----------------

All patients with trauma presenting to the University of California, Benioff Children's Hospital Oakland (BCHO) between 2006 and 2015 were retrospectively identified through the BCHO trauma registry. BCHO is a Level 1 pediatric trauma center in an urban area with approximately 800 trauma team activations each year. The BCHO trauma registry is a prospectively gathered comprehensive and consecutive list detailing all patients with an admitting diagnosis of trauma at BCHO. Once identified, inclusion and exclusion criteria as well as demographic information was verified in the entire cohort using the BCHO electronic health record. For patients that met criteria for inclusion and analysis, demographics, specifics of the trauma, significant events in the associated hospital course, and outcomes were extracted from the registry. Additional laboratory and outcome data along with missing data from the registry were retrospectively obtained from the BCHO electronic health record in the analyzed cohort. This study protocol was approved by the BCHO institutional review board.

Only patients with trauma and coagulation laboratories drawn at their presentation to the emergency room were included in the study. At BCHO during this study period, the decision to send coagulation studies was based on physician preference. Patients were excluded if they (1) were \>18 years of age, (2) were admitted with a non-mechanical mechanism of injury, specifically drowning, hanging, or burns, as these mechanisms may result in a different biologic response than mechanical trauma, (3) were on anticoagulation medications prior to injury, (4) had coagulation testing \>4 hours after the time of injury, and (5) received fresh frozen plasma prior to their laboratory draw.

Study variables {#s2-2}
---------------

The presence of ATC was the primary predictor variable and was defined as an international normalized ratio (INR) ≥1.3. This was selected as the predictor variable based on the use of INR as a definition of ATC in prior studies.[@R17] In the sub-analysis of mortality and organ dysfunction, ATC was defined as either an INR ≥1.3, a partial thromboplastin time (PTT) ≥35 s, or both. While definitions of ATC have varied in the literature, both cut-offs have been used in previous studies.[@R18]

The primary outcome was development of new or progressive MODS. New or progressive MODS was defined by Proulx *et al* as new organ dysfunction of two or more organ systems or progressive organ dysfunction of one organ system in addition to one already dysfunctional organ system.[@R22] To make this diagnosis, dysfunction of the cardiovascular, respiratory, neurologic, renal, hepatic, and gastrointestinal organ systems was determined for each of the 6 days following day 1 of trauma.[@R25] ([table 1](#T1){ref-type="table"}). For the purposes of this study, hematologic dysfunction was excluded from the MODS diagnostic criteria to capture organ dysfunction without confounding from the predictor variable. Secondary outcomes were in-hospital mortality, duration of hospitalization in survivors excluding in-patient rehabilitation, pediatric intensive care unit (PICU)-free days at day 28, mechanical ventilator-free days at day 28, readmission within 30 days after discharge, and development of pediatric acute respiratory distress syndrome (PARDS). PARDS was defined by the Pediatric Acute Lung Injury Consensus Conference definition as (1) acute onset within 7 days of trauma, (2) hypoxia demonstrated by either a partial pressure of oxygen in arterial blood (PaO2) to fraction of inspired oxygen (P/F) ratio \<300 or an oxygenation index \>4, (3) chest imaging showing a new pulmonary infiltrate consistent with parenchymal disease, and (4) respiratory findings not explained by cardiac failure or fluid overload.[@R27]

###### 

Criteria for organ dysfunction by the Proulx *et al* definition[@R22]

  Organ system       Criteria for dysfunction
  ------------------ ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Cardiovascular     HypotensionSystolic BP \<40 mm Hg for patients younger than 12 monthsSystolic BP \<50 mm Hg for patients 12 months or olderBradycardia or tachycardiaHeart rate \<50 or\>220 beats/min in patients younger than 12 monthsHeart rate \<40 or\>200 beats/min in patients 12 months or olderCardiac arrestSerum pH \<7.2 with normal arterial carbon dioxide levelContinuous IV infusion of inotropic agents to maintain BP and/or cardiac output
  Respiratory        TachypneaRespiratory rate \>90 breaths/min for patients younger than 12 monthsRespiratory rate \>70 breaths/min for patients 12 months or olderPaCO~2~ of \>65 mm HgPaO~2~ of \<40 mm HgRatio of PaO~2~ to fraction of inspired oxygen \<200 in the absence of cyanotic congenital heart disease
  Neurologic         Glasgow Coma Score \<5Fixed dilated pupils
  Renal              Serum blood urea nitrogen ≥100 mg/dLSerum creatinine ≥2 mg/dLDialysis or hemofiltration
  Hepatic            Total bilirubin level \>3 mg/dL
  Gastrointestinal   Evidence of gastroduodenal bleeding resulting in (1) a drop in hemoglobin of ≥2 g/dL over 24 hours, (2) blood transfusion, or (3) hypotension with BP less than third percentile for age

MODS was defined as new organ dysfunction of two or more organ systems or progressive organ dysfunction of one organ system in addition to one already dysfunctional organ system determined each of the 6 days following day 1 of trauma.[@R22]

BP, blood pressure; IV, Intravenous; MODS, multiple organ dysfunction syndrome; PaCO2, Partial pressure of arterial carbon dioxide; PaO2, Partial pressure of arterial oxygen.

Additional information including demographics, trauma mechanism, and medical interventions were also collected. Injury severity was assessed by the Injury Severity Score (ISS) which was considered as a continuous scale and categorized into mild (0--14), moderate (15-29), and severe (30-75) trauma.[@R28] Arterial hypotension was defined as a systolic blood pressure of \<60 mm Hg in neonates 0 to 30 days old, \<70 mm Hg in infants 30 days to 1 year old, \<70 mm Hg + (age in years x 2) mm Hg in children 1 year to 10 years old, and \<90 mm Hg in children and adolescents \> 10 years old based on reference points established in the Pediatric Advanced Life Support guidelines.[@R31]

Statistical analysis {#s2-3}
--------------------

Univariate and bivariate analyses were performed to evaluate patient demographics, specifics of injury, new or progressive MODS, mortality, and morbidity. Proportions of dichotomous data and medians of non-parametric continuous data were calculated with 95% CIs and p values. An α of 0.05 was preset as the cut-off for statistical significance. The χ^2^ test was used to compare proportions and categorical variables whereas the Mann--Whitney U test was used for comparison of continuous non-parametric data. Multivariable logistic regression was performed to assess ATC as an independent predictor of both new or progressive MODS and in-hospital mortality. Logistic regression was conducted in a stepwise way with inclusion of predictors based on biologic plausibility and/or a p value\<0.1 when included in the model. The number of variables was limited due to the number of outcomes available for the analysis. Ultimately, age, sex, presence of arterial hypotension, and ISS were included as covariates in the regression model. All analyses were performed using Stata/SE, V.14.1.[@R32]

Results {#s3}
=======

A total of 7382 pediatric patients with trauma presented to BCHO between 2006 and 2015 ([figure 1](#F1){ref-type="fig"}). Of those, 652 patients had coagulation tests drawn on presentation to the emergency department. In all, 107 patients met exclusion criteria which left 545 patients included in the final analysis. Based on the definition of ATC as an INR ≥1.3 on the initial laboratory draw and within 4 hours of the traumatic injury, 88 patients or 16% presented with ATC.

![CONSORT diagram of patients reviewed, included, and excluded. ATC, acute traumatic coagulopathy; BCHO, Benioff Children's Hospital Oakland; CONSORT, CONsolidated Standards Of Reporting Trials; FFP, fresh frozen plasma; INR, international normalized ratio.](tsaco-2019-000382f01){#F1}

Demographics and trauma specifics were gathered on the full 7382 pediatric patients with trauma and there was no significant difference in age, sex, race, ethnicity, or trauma mechanism between those included and excluded in the final analysis (data not shown). In the 545 patients included in the study, there was a higher proportion of Black or African American patients in the ATC group than in the group without ATC (27.3% compared with 17.5%, p=0.03, [table 2](#T2){ref-type="table"}). Otherwise, there was no difference in demographics between the two groups. Patients with ATC were less likely to have blunt trauma (83% compared with 92.6%, p=0.04) while a higher but not statistically significant percentage of patients with ATC had penetrating trauma (p=0.19). Among those that had blunt trauma, patients with non-accidental trauma were also more likely to present ATC (21.6% compared with 10.3%, p=0.003). In addition, there were also significantly more patients with an unknown trauma mechanism in the group with ATC (5.7% compared with 0.2%, p\<0.001), meaning the mechanism was not clearly described as blunt or penetrating in the BCHO trauma registry or the electronic medical record.

###### 

Demographic and injury characteristics of patients with and without ATC

                                                                                          ATC (n = 88)      No ATC (n = 457)   P value
  -------------------------------------------- ------------------------------------------ ----------------- ------------------ ---------
  Age                                          Median age (range)                         7y (30d -- 16y)   7y (5d -- 17y)     0.7
  Newborn, n (%)                               2 (2.3)                                    17 (3.7)          0.5                
  Infant, n (%)                                13 (14.8)                                  56 (12.3)         0.52               
  Toddler, n (%)                               12 (13.6)                                  55 (12)           0.68               
  Child, n (%)                                 39 (44.3)                                  201 (44)          0.95               
  Adolescent, n (%)                            22 (25)                                    128 (28)          0.56               
  Sex                                          Female, n (%)                              33 (38)           152(33.3)          0.96
  Race                                         American Indian or Alaskan Native, n (%)   1 (1.1)           2 (0.4)            0.42
  Asian, n (%)                                 6 (6.8)                                    32 (7)            0.95               
  Black or African American, n (%)             24 (27.3)                                  80 (17.5)         0.03               
  Native Hawaiian or Pacific Islander, n (%)   0 (0)                                      2 (0.4)           0.53               
  White, n (%)                                 50 (56.8)                                  285 (62.4)        0.33               
  Other, n (%)                                 7 (8)                                      56 (12.3)         0.25               
  Ethnicity                                    Hispanic, n (%)                            19 (21.6)         127 (27.8)         0.23
  Trauma mechanism                             Blunt, n (%)                               73 (83)           423 (92.6)         0.04
  Penetrating, n (%)                           10 (11.3)                                  33 (7.2)          0.19               
  Unknown, n (%)                               5 (5.7)                                    1 (0.2)           \<0.001            
  ISS                                          Median ISS (range)                         25 (0--75)        9 (0--38)          \<0.001

ATC is defined as an international normalized ratio ≥1.3. For breakdown by age newborns were 0 to 30 days old, infants were 31 to 364 days old, toddlers were 1 to 3 years old, children were 4 to 11 years old and adolescents were 12 to 18 years old.

ATC, acute traumatic coagulopathy; ISS, Injury Severity Score.

The median ISS for all patients presenting between 2006 and 2015 was 4, whereas the median for the analyzed cohort was 12. Patients with ATC had a higher median ISS (25 compared with 9, p\<0.001) and encompassed the full range of possible ISS values ([table 2](#T2){ref-type="table"}). Lower ISS categories were assigned to the majority of patients in the full cohort. With increasing ISS, the percent of patients with ATC increased ([figure 2](#F2){ref-type="fig"}). In the highest ISS category which contained only five patients, all patients had ATC.

![Percent of patients with ATC at each ISS category. \* indicates p\<0.001. ATC, acute traumatic coagulopathy; ISS, Injury Severity Score.](tsaco-2019-000382f02){#F2}

The overall development of new or progressive MODS in the full cohort was 16.9% (92 patients) and patients with ATC were more likely to develop MODS than those without ATC (68.4% compared with 7.7%, p\<0.001 ([table 3](#T3){ref-type="table"})). The overall mortality of patients presenting between 2006 and 2015 was 1.1% (81 patients) and of the analyzed cohort was 4.6% (25 patients). The mortality in patients with ATC was 26.1% (23 patients) and was significantly greater than the mortality of 0.4% (2 patients) in patients without ATC (p\<0.001). Patients with ATC were also more likely to develop PARDS, had a longer duration of hospitalization in survivors, had fewer PICU-free days at day 28, and had fewer mechanical ventilation-free days at day 28 than those without ATC.

###### 

Mortality and morbidity in patients with and without ATC defined by an INR ≥1.3.

                                              ATC (n=88)              No ATC (n=457)          
  ------------------------------------------- ----------------------- ----------------------- -------------
  **Complication and event outcomes**         **% (95% CI)**          **% (95% CI)**          **p value**
  Development of new or progressive MODS      64.8 (54.8 to 74.8)     7.7 (5.2 to 10.1)       \<0.001
  In-hospital mortality                       26.1 (17.6 to 36.5)     0.4 (0 to 1)            \<0.001
  Developed of PARDS                          35.2 (25.1 to 45.5)     3.5 (1.8 to 5.2)        \<0.001
  Readmission within 30 days of discharge     1.2 (1.1 to 3.5)        1.3 (0.3 to 2.4)        0.92
  **Duration outcomes**                       **Median days (IQR)**   **Median days (IQR)**   **p value**
  Duration of hospitalization in survivors    10 (7.7 to 12.3)        3 (2.8 to 3.2)          \<0.001
  PICU-free days at day 28                    17 (0 to 23)            26 (25 to 28)           \<0.001
  Mechanical ventilator-free days at day 28   21 (0 to 27)            28 (28 to 28)           \<0.001

New or progressive MODS was defined by the Proulx *et al* criteria and excludes hematologic dysfunction.[@R22] PARDS was defined by the pediatric acute lung injury consensus conference definition.[@R27] The total number of survivors in patients with ATC and without ATC was 63 and 455, respectively. Those that died were considered to have 0 PICU-free days and 0 mechanical ventilator-free days at day 28.

ATC, acute traumatic coagulopathy; INR, international normalized ratio; IQR, interquartile range; MODS, multiple organ dysfunction syndrome; PARDS, pediatric acute respiratory distress syndrome; PICU, pediatric intensive care unit.

New or progressive MODS in patients with an elevated INR was significantly greater than in those with a normal INR and did not vary in those with normal or elevated PTT ([table 4](#T4){ref-type="table"}). In patients with a normal INR, there was no difference between in-hospital mortality in patients with normal compared with an elevated PTT. However, patients with an elevated INR had a higher mortality with the highest in-hospital mortality seen in those with an elevated INR and PTT. Of note, there was no difference in injury severity between these two groups.

###### 

Mortality and new or progressive MODS in patients with ATC defined by an INR ≥1.3, PTT ≥35 s, or both

  -------------------------------------------------------------------------------------------
                                           PTT\<35 s\           PTT≥35 s\           P value
                                           % (95% CI)           % (95% CI)          
  ---------------------------------------- -------------------- ------------------- ---------
  Development of new or progressive MODS                                            

   INR \<1.3                               7.3 (4.8 to 9.9)     9.8 (2.4 to 17.3)   0.49

   INR ≥1.3                                64.1 (49 to 79.2)    65.3 (52 to 78.6)   0.91

   p value                                 \<0.001              \<0.001             

  In-hospital mortality                                                             

   INR \<1.3                               0.3 (0.2 to 0.7)     1.6 (1.5 to 4.8)    0.13

   INR ≥1.3                                15.4 (4.1 to 26.7)   34.7 (21.4 to 48)   0.04

   p value                                 \<0.001              \<0.001             
  -------------------------------------------------------------------------------------------

ATC, acute traumatic coagulopathy; CI, confidence interval; INR, international normalized ratio; MODS, multiple organ dysfunction syndrome; PTT, partial thromboplastin time.

On multivariable logistic regression, the presence of ATC was found to be an independent predictor of both new or progressive MODS and in-hospital mortality ([table 5](#T5){ref-type="table"}). Arterial hypotension and an ISS of ≥30 were also found to be independent predictors for both outcomes.

###### 

Multivariable logistic regression of effect on new or progressive MODS and in-hospital mortality

                                           OR    95% CI        P value
  ---------------------------------------- ----- ------------- ---------
  Development of new or progressive MODS                       
   ATC                                     2.7   2.1 to 3.4    \<0.001
   Arterial hypotension                    3.1   1.4 to 7.1    0.007
   ISS ≥30                                 4.6   1.8 to 11.5   0.001
  In-hospital mortality                                        
   ATC                                     4.2   2.4 to 7.2    \<0.001
   Arterial hypotension                    5.4   1.8 to 16.2   0.003
   ISS ≥30                                 4.9   1.7 to 14.3   0.004

ATC is defined by an INR ≥1.3

ATC, acute traumatic coagulopathy; CI, confidence interval; INR, international normalized ratio; ISS, injury severity score; MODS, multiple organ dysfunction syndrome; OR, odds ratio.

Discussion {#s4}
==========

We present here an examination of the incidence, modifiers, and associated outcomes of ATC in a pediatric population. In this large pediatric trauma cohort, ATC was present in 16% of included pediatric patients with trauma, was associated with worse injury, and was an independent predictor of in-hospital mortality. The consistency of this result with prior studies across different hospital settings and communities further confirms ATC as a significant entity across the pediatric trauma population.[@R17] Furthermore, ATC was an independent predictor of new or progressive MODS. This newly described relationship between ATC and MODS suggests the associated outcomes in ATC are more far reaching than previously described by mortality alone.

Another important set of findings in this study is the breakdown of organ dysfunction and mortality association by measure of coagulopathy. First and unsurprisingly, organ dysfunction and mortality were the highest in patients with elevations of both INR and PTT. This suggests global dysfunction of secondary hemostasis is seen in patients who do worse. Second, there was no statistically significant difference in association with organ dysfunction or mortality in those with an isolated elevated PTT compared with those with no coagulopathy. Third, an isolated INR coagulopathy was associated with an increase in both organ dysfunction and mortality from baseline and, in the case of organ dysfunction, carried the same association as a combined coagulopathy. Put another way, PTT seems to contribute to mortality but not to organ dysfunction. This result can be contrasted with a recent adult study which showed the highest mortality in patients with a combined INR and PTT coagulopathy but a higher mortality in an isolated PTT coagulopathy as compared with an isolated INR coagulopathy.[@R33]

It is unclear why this particular pattern is seen in the pediatric population. It may suggest that the extrinsic pathway as measured by INR is an important driver of organ dysfunction and mortality in pediatric ATC. Components of the coagulation system including Factors VII and X, which are important in the extrinsic pathway, do not develop fully until late childhood or early adolescence.[@R34] This lack of reserve may impact both organ dysfunction and mortality whereas factors in the intrinsic pathway may be more robust. Complicating this further, though the incidence of ATC is similar in adult and pediatric populations, children are much less likely to bleed in the presence of this coagulopathy than their adult counterparts. Therefore, the differences in INR and PTT may be more reflective of global hemostatic and endothelial dysfunction. Taken together, there may be key biologic differences in the development of ATC between children and adults even though the end result of poor outcomes is similar and these biologic differences require further mechanistic investigation in future studies.

Another interesting result that warrants future study and may help elucidate the underlying mechanism of ATC is the small population with low ISS (\<15) but with the presence of ATC. Though a small group of only 10 patients, 4 of these patients presented with penetrating injuries which is a much higher percentage than was seen in the total cohort and in those with ATC. This suggests there may be something unique about the mechanism of penetrating trauma that may be more likely to drive ATC. Further mechanistic study should focus on this subset of patients as potentially key in contributing mechanisms.

The strengths of this study include the relatively large sample size, the use of prospectively gathered data, and the consideration of organ dysfunction in addition to mortality as a meaningful outcome. There are several important limitations to this study. Specifically, though the BCHO trauma registry contains prospectively gathered data, these data were verified and supplemented through retrospective analysis and therefore carry limitations in data accuracy and control over measured variables. For example, the patients included in this study were only those with laboratory samples drawn at the time of admission. The results are not truly representative of all patients with trauma, but instead likely represent the sickest patients at the time of presentation. In addition, the BCHO trauma database is limited in the type of data it includes, particularly fluid and blood product administration as it relates to the timing of laboratory collection. Because the time to presentation to BCHO tended to be short and blood draws were done as close to the time of presentation as possible, it is reasonable that this effect is small but still deserves more careful consideration in future prospective work. Finally, as is true in many pediatric studies, there were a relatively small number of outcomes particularly mortality. This limited the number of covariates that could be included in the logistic regression analysis and may result in an estimate of effect with some residual confounding.

In summary, ATC is present following pediatric trauma and is associated with organ dysfunction, mortality, and other morbidities. ATC along with arterial hypotension and high injury severity are all independent predictors of mortality and organ dysfunction. Pediatric ATC may be biologically distinct from adult ATC and further prospective mechanistic studies are needed to characterize pediatric ATC and identify key pathways in this process.
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